Veracyte (VCYT) Invested Capital (2014 - 2026)

Veracyte has reported Invested Capital for 10 years, with the latest figure at $662000.0 in Q2 2026.

• Invested Capital for Q2 2026 came in at $662000.0, down 95.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $16.5 million (down 68.27% YoY), and the FY2025 annual result was $1.3 million, down 92.16% from the prior year.
• Invested Capital retreated to $662000.0 in Q2 2026, from $982000.0 in the prior quarter.
• Over five years, Invested Capital peaked at $17.0 million in Q4 2024 and troughed at $662000.0 in Q2 2026.
• A 5-year average of $6.4 million and a median of $6.0 million in 2022 frame the typical range for Invested Capital.
• The widest annual swing landed in 2024, when Invested Capital surged 539.1%; it then tumbled 95.07% in 2026.
• A 5-year view of Invested Capital shows it stood at $6.1 million in 2022, then sank by 56.16% to $2.7 million in 2023, then surged by 539.1% to $17.0 million in 2024, then plunged by 92.16% to $1.3 million in 2025, then sank by 50.3% to $662000.0 in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $662000.0 in Q2 2026, $982000.0 in Q1 2026, and $1.3 million in Q4 2025.